Status:
COMPLETED
Cardiac Arrhythmias in Greenland
Lead Sponsor:
Aalborg University Hospital
Conditions:
Atrial Fibrillation
Arrhythmia
Eligibility:
All Genders
50+ years
Brief Summary
The study is a phd-study comprising several substudies focusing on cardiac arrhythmias, mainly atrial fibrillation, among Greenlanders in Greenland. Some previous studies have indicated that the prev...
Detailed Description
Atrial fibrillation (AF) is the most common cardiac arrhythmia globally and a major risk factor for ischemic strokes, transient ischemic attacks, increased morbidity and mortality. Risk factors for A...
Eligibility Criteria
Inclusion
- At least 50 years old
- Greenlandic ethnicity based on parents' birth place.
- No history of cardiac disease or arrhythmia
Exclusion
- Celiac disease (for the SmartPill-study)
Key Trial Info
Start Date :
April 16 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 11 2024
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT05200676
Start Date
April 16 2022
End Date
March 11 2024
Last Update
March 15 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ilisimatusarfik
Nuuk, Greenland, 3900